Implementation of the COmmunity HEalth System InnovatiON Project in Low- and Middle- Income Countries
NCT ID: NCT06989502
Last Updated: 2025-05-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
2094 participants
INTERVENTIONAL
2025-05-17
2026-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
For this quasi-experimental study, three arms were established: the co-creation (2016 to 2019) + co-design (2023 to 2024) arm; the co-design only (2023 to 2024) arm; and the control group (no intervention; usual care). The evaluation will be composed of four types of evaluations: quantitative; qualitative; economic; and process evaluation
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Establish an Evaluation Scale for the Quality of Primary Care in Multi-professional Health Centres and Homes Integrating the Point of View of Patients in Complex Care Situations and Their Caregivers.
NCT05057520
Cocreating Action to Improve Rationality in the Health System
NCT07237971
Feasibility Study of a Novel mHealth Application to Enable Community Health Workers to Manage
NCT05479097
Interprofessional Collaborative Practice in Primary Care: Potentially Avoidable Hospitalization
NCT06420128
Measuring Ethnic Disparities in Family Planning Services in Peru
NCT01885858
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In this new phase, the COHESION-I project, which will be conducted from 2022 to 2026, the impact of a co-creation/co-design strategy will be evaluated in terms of two main outcomes: on the one hand, improved health system responsiveness at primary care level and patient satisfaction and, on the other hand, improved health care for chronic diseases. The general research objective of COHESION-I is to implement and evaluate at the primary health care level the co-created/co-designed interventions in the selected settings in each of the three countries (Mozambique, Nepal and Peru), focusing on Non-Communicable Diseases (diabetes, hypertension) and Neglected Tropical Diseases (schistosomiasis in Mozambique, Leprosy in Nepal and neurocysticercosis in Peru). This study involves the following evaluation components: quantitative evaluation, qualitative evaluation, economic evaluation, and process evaluation. There will be five trimesters in total for undertaking these different types of evaluations.
This study will implement a mixed-methods approach that includes a pre-post quasi-experimental study: a quantitative component that will accrue an initial survey and five repeated measurements over time with an embedded qualitative study.The study will be developed in three low- and middle-income countries: Mozambique, Nepal and Peru. In each country, the COHESION-I project will be implemented in six sites (A, B, C, D, E and F). From these six sites, two of them have already been selected (A and B sites). The A and B sites are the ones where the co-creation process was conducted between 2016 - 2019, and now, during the current phase, receive the co-designed intervention (co-created + co-designed). Sites C and D have been selected and they have similar characteristics as sites A and B. The difference is that in the previous phase of the COHESION project did not hold any previous activity in these settings. Participants in sites C and D are being engaged for the first time and will receive the same co-designed intervention as sites A and B, but without having been involved in the co-creation process (2016 to 2019). Finally, sites E and F, will share similar characteristics as sites A, B, C, and D, but they will receive no intervention (control sites or usual care).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Co-creation (2016 to 2019) + Co-design (2023 to 2024)
PERU:
* Radio programs with content related to health care
* Capacity building on management of diabetes, hypertension and neurocysticercosis
* Communication jar to prompt communication between health workers and patients
* Decentralized decision-making on facility improvement
NEPAL:
* Radio and pamphlets to promote Primary Health Care (PHC)
* Involvement of Female Community Health Volunteers
* Capacity building on management of diabetes, hypertension and lepra
* Flip charts, guidelines and posters for management of diseases and to prompt communication between health workers and patients
* Decentralized decision-making on facility improvement
MOZAMBIQUE:
* Radio and pamphlets informing population on hypertension, PHC and appointment system
* Facility based guideline/algorithm
* Capacity building on hypertension, diabetes and schistosomiasis
* Establishment of an "information booth"
* Group discussions on challenges and opportunities
* Advocacy on the issue of access to medicines
Co-creation (2016 to 2019) + Co-design (2023 to 2024)
It includes interventions implemented in a sequential way: a) The co-creation intervention (between 2016 and 2019), and b) the co-design intervention (between 2023 and 2024).
In this group of sequential interventions, relevant stakeholders have already been engaged in the project and they would be familiar with the intervention components. Their participation this time will enable updating and refining the previous co-creation intervention through the co-design process.
The intervention will encompass activities with the health service users and healthcare workers, in Peru, Nepal, and Mozambique
Co-design only (2023 to 2024)
PERU:
* Radio programs with content related to health care
* Capacity building on management of diabetes, hypertension and neurocysticercosis
* Communication jar to prompt communication between health workers and patients
* Decentralized decision-making on facility improvement
NEPAL:
* Radio and pamphlets to promote Primary Health Care (PHC)
* Involvement of Female Community Health Volunteers
* Capacity building on management of diabetes, hypertension and lepra
* Flip charts, guidelines and posters for management of diseases and to prompt communication between health workers and patients
* Decentralized decision-making on facility improvement
MOZAMBIQUE:
* Radio and pamphlets informing population on hypertension, PHC and appointment system
* Facility based guideline/algorithm
* Capacity building on hypertension, diabetes and schistosomiasis
* Establishment of an "information booth"
* Group discussions on challenges and opportunities
* Advocacy on the issue of access to medicines
Co-design only (2023 to 2024)
The same intervention activities of the first group (between 2023 and 2024), but without having them involved in the previous co-creation process. In consequence, relevant stakeholders in the corresponding sites are not expected to be as engaged in the project (in contrast to the intervention that includes co-creation), and they would not be very familiar with the intervention components of COHESION-I.
As in the first group, the intervention will encompass activities with the health service users and healthcare workers, in Peru, Nepal, and Mozambique
Control
Usual care, understood as the Primary Health Care (PHC) that the target patient population receives as part of the conventional or usual medical practice in each of their communities, in Peru, Nepal, and Mozambique
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Co-creation (2016 to 2019) + Co-design (2023 to 2024)
It includes interventions implemented in a sequential way: a) The co-creation intervention (between 2016 and 2019), and b) the co-design intervention (between 2023 and 2024).
In this group of sequential interventions, relevant stakeholders have already been engaged in the project and they would be familiar with the intervention components. Their participation this time will enable updating and refining the previous co-creation intervention through the co-design process.
The intervention will encompass activities with the health service users and healthcare workers, in Peru, Nepal, and Mozambique
Co-design only (2023 to 2024)
The same intervention activities of the first group (between 2023 and 2024), but without having them involved in the previous co-creation process. In consequence, relevant stakeholders in the corresponding sites are not expected to be as engaged in the project (in contrast to the intervention that includes co-creation), and they would not be very familiar with the intervention components of COHESION-I.
As in the first group, the intervention will encompass activities with the health service users and healthcare workers, in Peru, Nepal, and Mozambique
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having used the health services in the previous three months
* Diagnosis (or estimated risk) of diabetes mellitus type 2, hypertension, or neurocysticercosis
* Must be able to listen to radio programs, or other audio material
* Males or females aged 18 years and over, from the selected sites
* Having used the health services in the previous three months
* Must be able to listen to radio programs, or other audio material
Exclusion Criteria
The criteria mentioned above refer solely to the quantitative evaluation. For the other types of evaluation, some different populations will be included (such as healthcare workers, local authorities and other stakeholders).
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Eduardo Mondlane University
OTHER
B.P. Koirala Institute of Health Sciences
OTHER
Universidad Peruana Cayetano Heredia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
María Lazo Porras
Research Associate at CRONICAS
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
María Lazo-Porras, MD, MSc, PhD
Role: PRINCIPAL_INVESTIGATOR
Universidad Peruana Cayetano Heredia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Eduardo Mondlane University
Maputo, , Mozambique
B.P. Koirala Institute of Health Sciences
Dharān, , Nepal
Universidad Peruana Cayetano Heredia
Piura, , Peru
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Albertino Damasceno, MD, PhD
Role: primary
Sanjib Sharma, MD
Role: primary
María Lazo-Porras, MD, MSc, PhD
Role: primary
Antonio Bernabe-Ortiz, MD, MPH, PhD
Role: backup
References
Explore related publications, articles, or registry entries linked to this study.
Beran D, Lazo-Porras M, Cardenas MK, Chappuis F, Damasceno A, Jha N, Madede T, Lachat S, Perez Leon S, Aya Pastrana N, Pesantes MA, Singh SB, Sharma S, Somerville C, Suggs LS, Miranda JJ. Moving from formative research to co-creation of interventions: insights from a community health system project in Mozambique, Nepal and Peru. BMJ Glob Health. 2018 Nov 16;3(6):e001183. doi: 10.1136/bmjgh-2018-001183. eCollection 2018.
Pesantes MA, Somerville C, Singh SB, Perez-Leon S, Madede T, Suggs S, Beran D. Disruption, changes, and adaptation: Experiences with chronic conditions in Mozambique, Nepal and Peru. Glob Public Health. 2020 Mar;15(3):372-383. doi: 10.1080/17441692.2019.1668453. Epub 2019 Oct 9.
Cardenas MK, Perez-Leon S, Singh SB, Madede T, Munguambe S, Govo V, Jha N, Damasceno A, Miranda JJ, Beran D. Forty years after Alma-Ata: primary health-care preparedness for chronic diseases in Mozambique, Nepal and Peru. Glob Health Action. 2021 Jan 1;14(1):1975920. doi: 10.1080/16549716.2021.1975920.
Bernabe-Ortiz A, Perel P, Miranda JJ, Smeeth L. Diagnostic accuracy of the Finnish Diabetes Risk Score (FINDRISC) for undiagnosed T2DM in Peruvian population. Prim Care Diabetes. 2018 Dec;12(6):517-525. doi: 10.1016/j.pcd.2018.07.015. Epub 2018 Aug 18.
Related Links
Access external resources that provide additional context or updates about the study.
COHESION-I project description, hosted at the website of CRONICAS Center of Excellence in Chronic Diseases, at Universidad Peruana Cayetano Heredia
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIHR150261
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.